We are building a pipeline of in vivo and ex vivo therapies, as well as continuing to develop innovative modular platform capabilities.
Preclinical
Clinical
Clinical
- Lead refers to lead development and commercial party.
- * Intellia is advancing both wholly-owned and partnered programs.
- ** Nex-z (nexiguran ziclumeran), formerly known as NTLA-2001.
- *** Hemophilia B is being advanced by Regeneron. Intellia is eligible for milestones and royalties.
Download
Learn more

